International Conference on
Innovations in Pharma and Biopharma
Industry
(ICIPBI‐2017):
Challenges and Opportunities for
Academy and Industry
20‐22 December, 2017
Special Sessions
Regenerative Medicine
Innovations as Future
Medicine of 21st Century
Cancer and Infectious
Disease Research
– New
Drug Discovery and Development
Data Science
Workshop
Organizers:
University of Hyderabad
Hyderabad
With participation from:
Association of Biotechnology and Pharmacy
Conference
Indian pharma is transforming with biotech portfolio in
development of biologicals in both biosimilar and
novel molecules. The strong IT base, state of the art
infrastructure and large pool of scientific power can be
exploited for the design and development of
innovative therapeutics. There is a need to refocus
pharmaceutical research away from early discovery
activities by involving academia in the forefront in
partnership with industry to focus on emerging
technologies of therapeutic development. This shift in
the focus of the industry from early to current stage
drug discovery will enable the translation of publicly
funded research and lead to the cost‐effective
development of drugs. Moreover, they can overcome
the challenges in drug discovery like increasing costs,
decreasing productivity, and attrition of projects. This
requires strong linkages between academy and
industry. Push and Pull models have to be created
where ‘push’ from the academy and ‘pull’ from the
industry will help in more effective linkages for
innovative product developments. To make these
novel partnership models successful, sustainable
funding strategies required to be considered for
creation of specialized core facilities within the
academic institutions and stronger academy‐ industry
partnership need to be developed. In addition, there is
need to create an ideal environment for scientist‐
based start‐up enterprises focusing on innovation and
creativity. This not only creates job opportunities for
young graduates coming out of Universities and
Institutes, but also channelizes the early discoveries
towards innovative and novel products and thus nation
building.
Much of this translational work occurs through
collaborations between academic (basic as well as
clinical) and industrial institutions, taking advantage of
the respective strengths and resources of the all
sectors. However, such collaborations sometimes can
be challenging due to differences between the cultures
and priorities of the two parties. Under this scenario
the University of Hyderabad with participation of
Association of Biotechnology and Pharmacy (ABAP)
align itself with a national mission of start‐up India,
digital India, green India, and inclusive India and is
making efforts to organize ICIPBI‐2017 with a focus on
providing a platform for basic scientists, clinicians and
industrialists to come together and showcase their
strengths, expertise and explore collaborations so as to
promote novel discovery and development of pharma
and biopharmaceuticals.
Theme to be discussed
Diversity of Animal and Plant Diseases
New Drug Discovery and Development with
Natural Resources
Cancer Research
– Drug Discovery and
Development
Infectious diseases
Neurological Diseases
Cell based therapies for management of
diseases
Genome‐wide studies
Genetic and epigenetic basis of diseases
Transgenic Technology
– Human Welfare
Regenerative Medicine
Reproductive Biology
& Endocrinology
Monoclonals for therapy and diagnostics
Translational Research
Bioinformatics and data science– Human
welfare
Academia‐Industry interface
Regulatory issues
: Challenges and Opportunities for Academy and Industry | 20‐22 December, 2017){kind=link}
0 Comments